Rossby Financial
PVLA icon

Rossby Financial’s Palvella Therapeutics PVLA Stock Holding History

Rossby Financial’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-24
Closed -$3.67K – 2580
2026
Q2 		$3.67K Sell
24
-1
-4% -$121 ﹤0.01% 1556
2026
Q1 		$3.01K Buy
+25
New +$2.61K ﹤0.01% 1678

Other funds holding PVLA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return

Rossby Financial's PVLA Position: Q3 2026 in Review

Rossby Financial sold out of Palvella Therapeutics (PVLA) in Q3 2026, closing a stake of 24 shares — an estimated $3.67K sold.

Rossby Financial first reported a position in PVLA in Q1 2026 and held it in 2 quarters. The position peaked at $3.67K in Q2 2026. 141 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.

  • Rossby Financial reported no remaining Palvella Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Rossby Financial sold 24 Palvella Therapeutics shares in Q3 2026, an estimated $3.67K.
  • Rossby Financial first reported a position in Palvella Therapeutics in Q1 2026 and held it in 2 quarters.
  • Rossby Financial's Palvella Therapeutics position peaked at $3.67K in Q2 2026.
  • 141 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.

Based on Rossby Financial's 13F filing for Q3 2026, filed 5 Nov 2026.